 | |
- close
- close
|
PR Newswire
Nov 24
Comment
CHICAGO, Nov. 24 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for AIG, BIDU, PPG, JEF, and VRX. Seven Summits Strategic Investments' PriceWatch Alerts are available at http://www.iotogo.com/s/112409A (Note: You may have to copy
Market Intelligence Center
Nov 23
Comment
Valeant Pharmac. (NYSE: VRX) opened at $32.15. So far today, the stock has hit a low of $31.88 and a high of $32.95. VRX is now trading at $32.04, down $1.24 (-3.73%). Over the last 52 weeks the stock has ranged from a low of $15.64 to a high of...
PR Newswire
Nov 23
Comment
ALISO VIEJO, Calif., Nov. 23 /PRNewswire-FirstCall/ -- Oceanside Pharmaceuticals, part of Valeant Pharmaceuticals International (NYSE: VRX), today announced that it has now launched chlordiazepoxide hydrochloride and clidinium bromide, an authorized
PR Newswire
Nov 3
Comment
ALISO VIEJO, Calif., Nov. 3 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE: VRX) today announced that results from the week-72 analysis for its Phase IIb dose-finding clinical trial for taribavirin, a prodrug of ribavirin which is in
StreetInsider.com
Nov 2
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Valeant+Pharma+%28VRX%29+Posts+non-GAAP+EPS+of+%240.58%3B+Raises+FY09+EPS+Guidance/5063080.html for the full story.
PR Newswire
Nov 2
Comment
ALISO VIEJO, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced third quarter financial results for 2009. "Valeant continues to perform well, generating strong earnings growth in the third
PR Newswire
Oct 30
Comment
ALISO VIEJO, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it has agreed to acquire the rights to several prescription and cosmetic dermatology products from a privately-held, Polish
PR Newswire
Oct 23
Comment
ALISO VIEJO, Calif., Oct. 23 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Monday, November 2, 2009 at
StreetInsider.com
Oct 20
Comment
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Valeant+Pharma%27s+%28VRX%29+Coria+Labs+May+Market+Acanya+Gel+as+Effective+Treatment+for+Moderate+to+Severe+Acne/5029117.html for the full story.
|
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
|
||
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
VRX AT A GLANCE
References
| ||||||
|
|
